Search

Your search keyword '"Leonard, H"' showing total 198 results
Start Over Author "Leonard, H" Journal journal of the american academy of dermatology
198 results on '"Leonard, H"'

48. Nonablative fractional photothermolysis for facial actinic keratoses: 6-month follow-up with histologic evaluation

Author

Arash Kimyai-Asadi, Jennifer M. Landau, Leonard H. Goldberg, Tracy M. Katz, Denise Marquez, Paul M. Friedman, and Kristel D. Polder

Subjects
Male, medicine.medical_specialty, Time Factors, Keratosis, Lasers, Solid-State, Dermatology, Risk Assessment, Severity of Illness Index, Sampling Studies, Lesion, Severity of illness, Biopsy, Confidence Intervals, Odds Ratio, medicine, Humans, Prospective Studies, Low-Level Light Therapy, Prospective cohort study, Aged, medicine.diagnostic_test, business.industry, Biopsy, Needle, Actinic keratosis, Actinic keratoses, Middle Aged, medicine.disease, Immunohistochemistry, Confidence interval, Keratosis, Actinic, Treatment Outcome, medicine.symptom, business, Facial Dermatoses, Follow-Up Studies
Abstract

Background A number of epidermal and papillary dermal skin conditions can be treated safely and effectively with fractional photothermolysis (FP). Objective We sought to evaluate the effectiveness of FP with a 1550-nm fractionated erbium-doped fiber laser for the treatment of facial actinic keratoses (AKs). Methods Fourteen men, ages 59 to 79 years, underwent 5 laser treatments (2- to 4-week intervals) at an energy fluence of 20 to 70 mJ and treatment level of 11 (8-10 passes), corresponding to 32% to 40% surface area coverage. AK counts and photographs were taken at baseline, before each treatment, and at 1-, 3-, and 6-month follow-ups after the last treatment. Biopsies were performed at baseline and at the 3-month follow-up. The clinical improvement of the actinic lesions was evaluated by a dermatologist using digital photography and lesion counts at all 3 follow-up visits. Results The AK count for each patient was reduced on average by 73.1% (67.5%-77.7%) at the 1-month, 66.2% (60.0%-71.5%) at the 3-month, and 55.6% (43.9%-64.8%) at the 6-month follow-up visit. Excluding two cases, all biopsy specimens (baseline and at the 3-month follow-up) were positive for histologic features of AK and/or squamous cell carcinoma. Limitations This study is limited by a small number of patients; therefore further clinical studies are warranted. Conclusions FP decreases the number of clinical AKs; however, posttreatment biopsy specimens indicate the histologic persistence of AKs (epidermal tumors). FP is not an adequate single-treatment modality for AKs.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results